Journal
CLINICAL TRANSPLANTATION
Volume 21, Issue 4, Pages 554-557Publisher
BLACKWELL PUBLISHING
DOI: 10.1111/j.1399-0012.2007.00689.x
Keywords
anticoagulation; kidney-pancreas transplantation; thromboelastography
Categories
Ask authors/readers for more resources
Pancreas graft loss due to venous thrombosis is the leading non-immunological cause for graft failure following kidney-pancreas transplantation. Thromboelastography (TEG)-directed anticoagulation protocol has shown that approximately one-third of the patients undergoing pancreas transplantation require therapeutic anticoagulation to prevent the occurrence of graft thrombosis. This article presents the argument for individualised anticoagulation in these patients based on their TEG tracings and suggests the use of TEG in patients undergoing pancreas transplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available